glp 1 oral liquid GLP-1 Advanced Intra-Oral Spray, by Results RNA – Natural Healthy Concepts GLP-1 Oral Liquid Therapy for

Treatment isn't one-size-fits-all, and adjustments are a normal part of the process

The oral GLP-1 market has changed faster in the past six months than in the previous six years

dose-dependent response across 3, 6, and 9 mg arms Phase 3 T2D : HbA1c reductions up to 2.15% versus placebo in Chinese population trials Phase 1b/2 data : Earlier dose-finding studies establishing the efficacy and tolerability profile Global development : Ongoing clinical trials outside China, but no FDA approval or submission as of early 2026 Limitation : Primary clinical data from Chinese population

In IIH, use of exenatide to reduce ICP did not have a negative impact on cognition at 12 weeks